# Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy

> **NCT01855360** · PHASE1,PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 40 (actual)

## Conditions studied

- Amyloidosis; Heart (Manifestation)
- Senile Cardiac Amyloidosis

## Interventions

- **DRUG:** Tauroursodeoxycholic Acid and Doxycycline

## Key facts

- **NCT ID:** NCT01855360
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2015-05-31
- **Final completion:** 2015-05-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01855360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01855360, "Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01855360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*